Gain Therapeutics, Inc. GANX
Set alert
1.13 USD 0.00 0.00%
At close · Nov 2
1.13 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
1.12 Day range 1.20
1.11 52-week range 4.34
- YTD
- -64.91%
- 1 year
- -42.35%
- Open
- 1.15
- Prev close
- 1.13
- Mkt cap
- 49.32M
- Vol
- 268.67K
- Avg vol
- 501.97K
- EPS
- -0.50
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.12
- High
- 1.20
- Forward P/E
- -1.76
- Beta
- 0.34
- Short ratio
- 1.65
- Inst. own
- 7.96%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 2.05
- 200-d avg
- 2.12
- 1y target
- 7.33
Analyst view
Consensus: none
Price target (mean) 7.33 +549.0% upside
Now 1.13
- Target (low)
- 5.00
- Target (mean)
- 7.33
- Target (high)
- 10.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy3
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 5
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.17333 | -0.18 – -0.17 | -0.29 | +40.2% | 0 | 0.0% | 3 |
| Next quarter | -0.17667 | -0.18 – -0.17 | -0.22 | +19.7% | 33.33K | 0.0% | 3 |
| Current year | -0.97667 | -0.99 – -0.95 | -1.71 | +42.9% | 0 | -100.0% | 3 |
| Next year | -0.785 | -1.15 – -0.57 | -0.97667 | +19.6% | 40.00K | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | Roth MKM | Initiated | — | Buy |
| Nov 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 9, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Jul 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 2, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 28, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 23, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 27, 2024 | Chardan Capital | Reiterated | Buy | Buy |
| Dec 4, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 18, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 12, 2023 | Maxim Group | Initiated | — | Buy |
| Aug 31, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| Aug 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 12, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2023 | Chardan Capital | Maintained | Buy | Buy |
| May 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 27, 2023 | Chardan Capital | Maintained | — | Buy |
| Dec 9, 2022 | Chardan Capital | Initiated | — | Buy |
| Nov 25, 2022 | Oppenheimer | Maintained | — | Outperform |
| Nov 14, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 14, 2022 | BTIG | Maintained | — | Buy |